Medicine and Health Sciences Commons^™

Sharksrx Newsletter Summer 2023, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Sharksrx Newsletter Spring 2023, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Sharksrx Newsletter Fall 2022, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Sharksrx Newsletter Summer 2022, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Sharksrx Newsletter Spring 2022, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Sharksrx Newsletter Fall 2021, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Sharksrx Newsletter Summer 2021, Nova Southeastern University

NSU Sharks Rx

No abstract provided.

Facilitating The Everyday Steward: Impact Of Mandatory Antimicrobial Indication/Duration And A 48 Hour Time Out, Ann L. Wirtz, Alaina N. Burns, Brian R. Lee, Tammy Frank, Laura Fitzmaurice, Richard Ogden, Brian O'Neal, Jennifer Goldman

Posters

Introduction: Required indication, duration, and a 48-hour antimicrobial timeout are an integral part of antimicrobial stewardship standards; however, limited data are available to demonstrate an effect on antimicrobial utilization and antimicrobial stewardship practice. Therefore, we evaluated the impact of mandatory declared indication/duration along with a pharmacy-driven 48-hour timeout on antimicrobial utilization and antimicrobial stewardship interventions.

Methods: We performed a retrospective evaluation of ASP interventions and antimicrobial use following implementation of mandatory antimicrobial indication/duration at the point of computerized physician order entry (CPOE). A pharmacist-driven 48-hour antimicrobial timeout was introduced on the same date. This study was conducted at Children’s Mercy …

Religion, Jacob Grasser, Meiling G. Norfolk, Ashton Prusia

Introduction to Public Health Posters

Pharmacists should be well-trained and sensitive to patient religious concerns and proactive in their research of any drug ingredients that may conflict with a patient's beliefs. Pharmaceutical manufacturing companies should be comprehensive in their product labeling to accommodate religious sensitivities.